Hadler S - Search Results

1

The safety of acellular pertussis vaccine vs whole-cell pertussis vaccine. A postmarketing assessment.

Rosenthal S, Chen R, Hadler S. Rosenthal S, et al. Among authors: hadler s. Arch Pediatr Adolesc Med. 1996 May;150(5):457-60. doi: 10.1001/archpedi.1996.02170300011001. Arch Pediatr Adolesc Med. 1996. PMID: 8620224

2

Vaccine Safety Datalink project: a new tool for improving vaccine safety monitoring in the United States. The Vaccine Safety Datalink Team.

Chen RT, Glasser JW, Rhodes PH, Davis RL, Barlow WE, Thompson RS, Mullooly JP, Black SB, Shinefield HR, Vadheim CM, Marcy SM, Ward JI, Wise RP, Wassilak SG, Hadler SC. Chen RT, et al. Among authors: hadler sc. Pediatrics. 1997 Jun;99(6):765-73. doi: 10.1542/peds.99.6.765. Pediatrics. 1997. PMID: 9164767

3

The risk of Guillain-Barré syndrome after tetanus-toxoid-containing vaccines in adults and children in the United States.

Tuttle J, Chen RT, Rantala H, Cherry JD, Rhodes PH, Hadler S. Tuttle J, et al. Among authors: hadler s. Am J Public Health. 1997 Dec;87(12):2045-8. doi: 10.2105/ajph.87.12.2045. Am J Public Health. 1997. PMID: 9431302 Free PMC article. Review.

4

Respiratory diphtheria in the United States, 1980 through 1995.

Bisgard KM, Hardy IR, Popovic T, Strebel PM, Wharton M, Chen RT, Hadler SC. Bisgard KM, et al. Among authors: hadler sc. Am J Public Health. 1998 May;88(5):787-91. doi: 10.2105/ajph.88.5.787. Am J Public Health. 1998. PMID: 9585746 Free PMC article. Review.

5

Economic evaluation of use of diphtheria, tetanus, and acellular pertussis vaccine or diphtheria, tetanus, and whole-cell pertussis vaccine in the United States, 1997.

Ekwueme DU, Strebel PM, Hadler SC, Meltzer MI, Allen JW, Livengood JR. Ekwueme DU, et al. Among authors: hadler sc. Arch Pediatr Adolesc Med. 2000 Aug;154(8):797-803. doi: 10.1001/archpedi.154.8.797. Arch Pediatr Adolesc Med. 2000. PMID: 10922276

6

Utility of large-linked databases in vaccine safety, particularly in distinguishing independent and synergistic effects. The Vaccine Safety Datalink Investigators.

Wassilak SG, Glasser JW, Chen RT, Hadler SC. Wassilak SG, et al. Among authors: hadler sc. Ann N Y Acad Sci. 1995 May 31;754:377-82. doi: 10.1111/j.1749-6632.1995.tb44473.x. Ann N Y Acad Sci. 1995. PMID: 7625677 No abstract available.

7

Vaccination in the immunocompromised person.

Grabowsky M, Hadler SC, Chen RT, Edwards KM. Grabowsky M, et al. Among authors: hadler sc. Bull Rheum Dis. 1995 Dec;44(8):3-6. Bull Rheum Dis. 1995. PMID: 8528436 Review. No abstract available.

8

Risk of hospitalization because of aseptic meningitis after measles-mumps-rubella vaccination in one- to two-year-old children: an analysis of the Vaccine Safety Datalink (VSD) Project.

Black S, Shinefield H, Ray P, Lewis E, Chen R, Glasser J, Hadler S, Hardy J, Rhodes P, Swint E, Davis R, Thompson R, Mullooly J, Marcy M, Vadheim C, Ward J, Rastogi S, Wise R. Black S, et al. Among authors: hadler s. Pediatr Infect Dis J. 1997 May;16(5):500-3. doi: 10.1097/00006454-199705000-00009. Pediatr Infect Dis J. 1997. PMID: 9154545

9

Potential impact on vaccination coverage levels by administering vaccines simultaneously and reducing dropout rates.

Dietz VJ, Stevenson J, Zell ER, Cochi S, Hadler S, Eddins D. Dietz VJ, et al. Among authors: hadler s. Arch Pediatr Adolesc Med. 1994 Sep;148(9):943-9. doi: 10.1001/archpedi.1994.02170090057008. Arch Pediatr Adolesc Med. 1994. PMID: 8075738

10

Risk of chronic arthropathy among women after rubella vaccination. Vaccine Safety Datalink Team.

Ray P, Black S, Shinefield H, Dillon A, Schwalbe J, Holmes S, Hadler S, Chen R, Cochi S, Wassilak S. Ray P, et al. Among authors: hadler s. JAMA. 1997 Aug 20;278(7):551-6. JAMA. 1997. PMID: 9268275

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

194 results

Search Page